2 days ago · GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, …

To pursue a mission like GRAIL’s, it takes all of us—a unified collective of courageous, adaptable, and open-minded big thinkers dedicated to creating a better world.

Jun 18, 2025 · GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, …

Sep 23, 2025 · GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, …

May 22, 2023 · GRAIL’s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk …

Multi-cancer early detection (MCED) testing is a new approach to screening for cancer. Adding a blood-based multi-cancer early detection test can help screen for many of the deadliest cancers that don’t …

Oct 16, 2025 · GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, …

The test detected cell-free DNA from cancer present in the mother’s blood. In 2016, Illumina spun out a separate entity to focus on researching this incredible discovery, naming it GRAIL because the co …

Sep 30, 2024 · GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, …

Feb 12, 2025 · GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, …